CLOVIS ONCOLOGY INC's ticker is and the CUSIP is 189464AB6. A total of 14 filers reported holding CLOVIS ONCOLOGY INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $47,809,000 | +3.2% | 49,064,000 | 0.0% | 0.85% | -12.8% |
Q1 2021 | $46,323,000 | +2.4% | 49,064,000 | 0.0% | 0.97% | +8.9% |
Q4 2020 | $45,236,000 | +2.5% | 49,064,000 | 0.0% | 0.89% | -16.8% |
Q3 2020 | $44,114,000 | +0.2% | 49,064,000 | 0.0% | 1.07% | -16.2% |
Q2 2020 | $44,037,000 | +1.0% | 49,064,000 | 0.0% | 1.28% | -7.3% |
Q1 2020 | $43,581,000 | +1.6% | 49,064,000 | 0.0% | 1.38% | +1.0% |
Q4 2019 | $42,905,000 | +1.5% | 49,064,000 | 0.0% | 1.37% | -20.5% |
Q3 2019 | $42,262,000 | +165.8% | 49,064,000 | +172.6% | 1.72% | +201.8% |
Q2 2019 | $15,902,000 | +242.2% | 18,000,000 | +260.0% | 0.57% | +220.8% |
Q1 2019 | $4,647,000 | -72.6% | 5,000,000 | -69.7% | 0.18% | -74.5% |
Q4 2016 | $16,979,000 | – | 16,500,000 | – | 0.70% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
QVT Financial LP | 43,295,000 | $29,665,000 | 1.82% |
Telemetry Investments, L.L.C. | 7,000,000 | $4,747,000 | 1.38% |
Baker Brothers Advisors | 129,300,000 | $87,801,000 | 0.93% |
Castle Creek Arbitrage, LLC | 5,500,000 | $3,755,000 | 0.30% |
WOLVERINE ASSET MANAGEMENT LLC | 14,300,000 | $9,730,000 | 0.28% |
Verition Fund Management LLC | 1,966,000 | $1,343,000 | 0.22% |
UBS OCONNOR LLC | 11,625,000 | $7,960,000,000 | 0.15% |
CAPSTONE INVESTMENT ADVISORS, LLC | 6,000,000 | $4,106,000 | 0.12% |
PFM Health Sciences, LP | 4,747,000 | $3,243,000 | 0.10% |
ARROWGRASS CAPITAL PARTNERS (US) LP | 11,500 | $3,568,000 | 0.04% |